ESR1 and breast carcinoma: It is well known that there is cross-talk between MAP kinase and/or PI3K/AKT signal transduction pathways and ERα in breast cancer cells, which promotes an increase in estrogen-mediated signaling and favors recruitment of coactivators, such as SRC-1 and SRC-3 [22,23].